Labyrinthitis (Otitis Interna)

10/01/1960 - "[On the prognosis of infectious labyrinthitis under the influence of antibiotics]."
01/01/2004 - "The objective of this review was to assess the effects of local and/or systemic antibiotics for preventing complications such as postoperative discharge, graft failure and labyrinthitis in patients undergoing clean or clean-contaminated ear surgery. "
07/01/2011 - "GBE has potential as an adjunctive therapy to antibiotics in the treatment of acute otitis media with complicated labyrinthitis."
04/01/1960 - "Bilateral subactue otitis media, with labyrinthitis and total loss of usable hearing: resistance to antibiotics."
01/01/2004 - "There is no strong evidence that the large scale use of prophylactic of antibiotics in clean and clean-contaminated ear surgery is helpful in reducing postoperative complications such as wound infection, discharge from the outer ear canal, labyrinthitis and graft failure."

07/01/2006 - "TNFalpha blockers do not improve the hearing recovery obtained with glucocorticoid therapy in an autoimmune experimental labyrinthitis."
09/01/2008 - "Tumor necrosis factor alpha is sufficient to recruit inflammatory cells to the cochlea but is not likely to be directly responsible for the hearing loss that follows immune-mediated labyrinthitis."
09/01/2008 - "Competitive inhibition of TNF-alpha receptors reduces inflammation and hearing loss in experimentally induced labyrinthitis in guinea pigs and mice. "
07/01/2006 - "The efficacy of etanercept (anti-TNFalpha) was evaluated in a guinea pig model of experimental autoimmune labyrinthitis in which 25 guinea pigs were divided in a control group, which was used to document the rise in hearing thresholds following immunisation, and two experimental groups, which were treated with steroids (6-methylprednisolone) and anti-TNFalpha (etanercept), respectively, after the immunisation. "
07/01/2006 - "The effectiveness of etanercept [tumour necrosis factor-alpha (TNFalpha) blocker] and corticoids in treating immuno-mediated inner ear disease (IMIED) was compared in an animal model of autoimmune labyrinthitis. "

02/01/2001 - "Preventing labyrinthitis ossificans: the role of steroids."
02/01/2001 - "The results of this retrospective study are highly suggestive of a role for steroids in preventing the development of labyrinthitis ossificans in children with pneumococcal meningitis."
02/01/2001 - "To identify a possible relationship between the administration of steroids at the time of diagnosis of bacterial meningitis and the development of labyrinthitis ossificans. "
07/01/2006 - "The efficacy of etanercept (anti-TNFalpha) was evaluated in a guinea pig model of experimental autoimmune labyrinthitis in which 25 guinea pigs were divided in a control group, which was used to document the rise in hearing thresholds following immunisation, and two experimental groups, which were treated with steroids (6-methylprednisolone) and anti-TNFalpha (etanercept), respectively, after the immunisation. "

01/01/2003 - "Etanercept will be able to reduce the inflammation and hearing loss associated with experimentally induced labyrinthitis. "
07/01/2006 - "We therefore conclude that etanercept is as effective as glucocorticoids in an animal model of autoimmune labyrinthitis; however, the potential adverse effects and high price of the former advise against its use as an initial therapy for IMIED."
07/01/2006 - "The efficacy of etanercept (anti-TNFalpha) was evaluated in a guinea pig model of experimental autoimmune labyrinthitis in which 25 guinea pigs were divided in a control group, which was used to document the rise in hearing thresholds following immunisation, and two experimental groups, which were treated with steroids (6-methylprednisolone) and anti-TNFalpha (etanercept), respectively, after the immunisation. "
07/01/2006 - "The effectiveness of etanercept [tumour necrosis factor-alpha (TNFalpha) blocker] and corticoids in treating immuno-mediated inner ear disease (IMIED) was compared in an animal model of autoimmune labyrinthitis. "

05/20/1967 - "Tetracycline as a cure for rolling disease (labyrinthitis) in laboratory rats."

05/01/1999 - "To establish the therapeutic efficacy of acyclovir (Zovirax) and prednisolone in experimental HSV-1 viral labyrinthitis, we induced HSV-1 labyrinthitis in 12 guinea pigs. "

07/01/2006 - "We therefore conclude that etanercept is as effective as glucocorticoids in an animal model of autoimmune labyrinthitis; however, the potential adverse effects and high price of the former advise against its use as an initial therapy for IMIED."

09/01/1995 - "It is concluded that ceftazidime should be a very useful agent in the treatment of bacterial labyrinthitis caused by susceptible organisms."

05/01/1999 - "To establish the therapeutic efficacy of acyclovir (Zovirax) and prednisolone in experimental HSV-1 viral labyrinthitis, we induced HSV-1 labyrinthitis in 12 guinea pigs. "

09/01/2000 - "The aim of the present study was to establish an animal model of autoimmune labyrinthitis using heterologous inner ear antigen (IEAg) and to elucidate whether the experimentally induced labyrinthitis could be passively transferred. "
12/01/2007 - "Acute labyrinthitis was generated by injection of antigen into the scala tympani of sensitized guinea pigs. "
05/01/2004 - "Because animal models of autoimmune labyrinthitis have been developed by means of different antigens, we cannot yet show a valid immunopathologic explanation. "
01/01/1999 - "These results suggest that the inner ear may possess cross-species organ-specific antigen and that a cell-mediated immune reaction may play an important role in the induction of autoimmune labyrinthitis."
03/01/1993 - "In experimental autoimmune labyrinthitis, we found that the guinea pigs sensitized with bovine inner ear antigen (IEAg) developed cellular infiltration within the endolymphatic sac (E. "

01/01/1992 - "None with continuous grafts had labyrinthitis. "
01/01/2004 - "infection, discharge, graft failure, labyrinthitis, adverse effects of prophylaxis. "
11/01/1994 - "As a result, the data indicates that cochlear implantation does not increase the risk of labyrinthitis following pneumococcal otitis media, but it is desirable to use fascia as a graft to the round window around the electrode entry point."
01/01/2004 - "The objective of this review was to assess the effects of local and/or systemic antibiotics for preventing complications such as postoperative discharge, graft failure and labyrinthitis in patients undergoing clean or clean-contaminated ear surgery. "
01/01/2004 - "There is no strong evidence that the large scale use of prophylactic of antibiotics in clean and clean-contaminated ear surgery is helpful in reducing postoperative complications such as wound infection, discharge from the outer ear canal, labyrinthitis and graft failure."

12/01/2015 - "The Impact of Postmeningitic Labyrinthitis Ossificans on Speech Performance After Pediatric Cochlear Implantation."
09/01/2013 - "Cochlear implantation (CI) is the treatment of choice in bilateral labyrinthitis ossificans (LO). "
05/01/2009 - "To describe a cadaveric temporal bone model of labyrinthitis ossificans and investigate the utility of intraoperative cone-beam computed tomography (CBCT) in the facilitating cochlear implantation. "
01/01/2005 - "Computed tomography is an appropriate method of examination for the identification of labyrinthitis ossificans and is of particular importance for the evaluation of patients before cochlear implantation."
09/01/2004 - "Magnetic resonance imaging at four weeks following injury showed evidence of developing labyrinthitis ossificans and a decision was made to perform bilateral cochlear implantation at an early stage. "

01/01/2000 - "Compressed electrode arrays in cases of obliterative labyrinthitis ossificans."
05/01/1992 - "The commonest abnormality shown in these cases is post-meningitic or tympanogenic labyrinthitis ossificans, which can obstruct the passage of the electrode. "
05/01/1992 - "Unintentional scala media insertion of the electrode array resulted from labyrinthitis ossificans obliteration of the scala tympani. "
12/01/2008 - "Middle-turn cochleostomies are occasionally used for cochlear implant electrode placement in patients with labyrinthitis ossificans. "
03/01/1991 - "Labyrinthitis ossificans may be a hindrance to cochlear implantation by making electrode insertion difficult. "

12/01/2003 - "Case report: explantation of a cochlear implant secondary to chronic granulating labyrinthitis."
10/01/2000 - "Labyrinthitis ossificans is a recently recognized entity with the extending cochlear implant surgery. "
01/01/1996 - "Successful revision of failed cochlear implants in severe labyrinthitis ossificans."
12/01/2008 - "Middle-turn cochleostomies are occasionally used for cochlear implant electrode placement in patients with labyrinthitis ossificans. "
02/01/1980 - "The advent of the cochlear implant makes ossification of the cochlea (labyrinthitis ossificans) of more than academic interest, since it requires alteration of the insertion of an electrode into the scala tympani and minimizes the chances of successful stimulation. "

06/01/1962 - "[Serous postoperative labyrinthitis in stapes surgery]."
12/01/2007 - "[Labyrinthitis, or inflammatory pseudotumor after stapedectomy]."
10/01/2000 - "In this paper we present a 33-year-old woman with a small unilateral air-bone gap, who developed bacterial labyrinthitis with meningitis and anacusis three days after stapes surgery. "
01/01/1977 - "Temporal bone histopathology is reported on a case of acute suppurative otitis media, acute suppurative labyrinthitis, and meningitis with death of the patient 20 days after stapes surgery. "
07/01/1997 - "The causes of hearing loss were believed to be labyrinthitis through the fistula in cholesteatoma case 1, and acoustic trauma from the bone-cutting burr in cases 2 and 3. In cases 4 and 5 postoperative sensorineural hearing loss occurred several months after stapes surgery and the causes of hearing loss were unknown. "